Literature DB >> 9010867

Pigmented ocular fundus lesions and APC mutations in familial adenomatous polyposis.

E I Traboulsi1, J Apostolides, F M Giardiello, A J Krush, S V Booker, S R Hamilton, I E Hussels.   

Abstract

BACKGROUND: Familial adenomatous polyposis (FAP) results from a germline mutation in the adenomatous polyposis coli (APC) gene on chromosome 5q21. The extracolonic manifestations of FAP include pigmented ocular fundus lesions (POFLS), cutaneous cysts, osteomas, occult radio-opaque jaw lesions, odontomas, desmoids, and extracolonic cancers. POFLS are present at birth in about 80% of patients with FAP and are excellent clinical congenital markers for the disease. We studied the distribution of POFLS by number and APC mutation in families of the Johns Hopkins Polyposis Registry.
MATERIALS AND METHODS: Of the 51 families with FAP, 42 (82%) had an identifiable APC mutation. We correlated the presence/absence and distribution by number of POFLS with the type and location of the mutation in the APC gene in 21 families where an ocular examination had been performed in at least one affected member, and where a systematic search for mutations in the APC gene had been undertaken. Families were considered POFL-positive if the average number of lesions per patient was three or more, or if at least one family member had three or more lesions.
RESULTS: Fifteen of the 21 families (71.4%) were POFL-positive. Mutations of the APC gene were detected in 15 of the 21 families. Of these, 12 (80%) were POFL-positive. Families with mutations at condons 215 (exon 5) and 302 (exon 8) were POFL-negative. Families with mutations at condons 541, 625, 1055, 1059, 1061, 1230, 1309, 1465, and 1546 (exons 12-15) were POFL-positive. One patient with a mutation at codon 2621 (exon 15) had no POFLS.
CONCLUSIONS: Mutations in exons 1-8 and the distal portion of exon 15 of the APC gene are associated with a POFL-negative phenotype, while those in exons 10 to the proximal portion of exon I5 are generally associated with a POFL-positive

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9010867     DOI: 10.3109/13816819609057890

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN: 1381-6810            Impact factor:   1.803


  5 in total

1.  Congenital hypertrophy of the retinal pigment epithelium (CHRPE) in familial colorectal cancer.

Authors:  Celia S Chen; Kerry D Phillips; Scott Grist; Graeme Bennet; Jamie E Craig; James S Muecke; Graeme K Suthers
Journal:  Fam Cancer       Date:  2006-08-31       Impact factor: 2.375

2.  Diplopia as presenting sign of Turcot syndrome.

Authors:  Virginie G S Ninclaus; Sophie Walraedt; Edward Baert; Geneviève Laureys; Bart P Leroy; Julie De Zaeytijd
Journal:  Int Ophthalmol       Date:  2016-05-03       Impact factor: 2.031

Review 3.  [Retinal tumors in adults: Part 2 nonvascular tumors of retina and retinal pigment epithelium].

Authors:  Roya Piria; Felix Rommel; Michael Zimbelmann; Kristina Erikson; Neele Babst; Anton Brosig; Josephine Christin Freitag; Mahdy Ranjbar; Salvatore Grisanti; Vinodh Kakkassery
Journal:  Ophthalmologe       Date:  2021-07-29       Impact factor: 1.059

4.  Congenital hypertrophy of retinal pigment epithelium (CHRPE) in patients with familial adenomatous polyposis (FAP); a polyposis registry experience.

Authors:  Anwer Nusliha; Ushantha Dalpatadu; Binara Amarasinghe; Pramodh Chitral Chandrasinghe; Kemal Ismail Deen
Journal:  BMC Res Notes       Date:  2014-10-18

Review 5.  Congenital Hypertrophy of the Retinal Pigment Epithelium (CHRPE) as a Screening Marker for Familial Adenomatous Polyposis (FAP): Systematic Literature Review and Screening Recommendations.

Authors:  Louis Antoine Bonnet; R Max Conway; Li-Anne Lim
Journal:  Clin Ophthalmol       Date:  2022-03-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.